1. Avgerinos, A. and Malamataris, S., High performance liquid chromatographic determination of niflumic acid in human plasma and urine.J. Chromatogr., 533, 271–274 (1990).
2. Grossman, A. and Besser, G.M., Prolactinomas.Br. Med. J., 290, 182–184 (1985).
3. Kim, H. J., Pharmacokinetics of talniflumate, a prodrug of niflumic acid, following oral administration to human. MS theis, College of Pharmacy, Seoul National University, 1994.
4. Lan, S. J., Chando, T. J., Weliky, I. and Schreiber, E. C., Metabolism of niflumic acid-14C: absorption, excretion and biotransformation by human and dog.J. Pharmacol. Exp. Ther., 186, 323–330 (1973).
5. Lancranjan, I., The endocrine profile of bromocriptione: its application in endocrine diseases.J. Neural. Transm., 51, 61–82 (1981).